A new possibility for managing cardiovascular disease through RNA interference (RNAi) gene therapies. As cardiovascular diseases continue to be the leading cause of death globally, this technology ...

BOSTON —Small interfering RNA technology has the potential to become a novel treatment approach in cardiovascular medicine, according to Clyde W. Yancy, MD, MSc, MACP, MACC, FAHA, FHFSA. In this ...

Small interfering RNA (siRNA) drugs are a class of therapeutic agents that silence specific genes associated with inherited diseases. However, siRNA drugs have challenges because siRNAs often ...

Small interfering RNA (siRNA) is a class of double-stranded RNA molecules, typically 20-25 base pairs in length, that play a crucial role in the RNA interference (RNAi) pathway. siRNAs are involved in ...

Different levels of two neuropeptides can turn leafcutter ants into soldiers, farmers, or nurses, highlighting their role in ...

Scientists have learned how plants keep viruses from being passed to their offspring, a finding that could ensure healthier crops. The discovery could also help reduce the transmission of diseases ...

Lepodisiran is a small interfering RNA inhibitor designed to inhibit the production of Lp (a).The ALPACA phase 2 trial enrolled 320 participants with Lp (a) levels of 175 nmol/L or higher.